<DOC>
	<DOCNO>NCT02238080</DOCNO>
	<brief_summary>This observational , multi-center , open-label , prospective study evaluate relationship serum interleukin-6 ( IL-6 ) C-reactive protein ( CRP ) level methoxy polyethylene glycol-epoetin beta dosage participant chronic kidney disease ( CKD ) dialysis . Participants recruit stable methoxy polyethylene glycol-epoetin beta maintenance therapy initiate therapy methoxy polyethylene glycol-epoetin beta .</brief_summary>
	<brief_title>An Observational Study Methoxy Polyethylene Glycol-Epoetin Beta ( Mircera ) Chronic Kidney Disease Participants Dialysis</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>CKD participant undergo dialysis Participants initiate ESA treatment methoxy polyethylene glycolepoetin beta participant stable methoxy polyethylene glycolepoetin beta maintenance therapy Adequate iron status define : serum ferritin equal 100 microgram per liter ( mcg/L ) transferrin saturation equal 20 percent ( % ) Conditions know cause inadequate response ESA treatment Anemia symptomatic anemia associate CKD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>